Id |
Subject |
Object |
Predicate |
Lexical cue |
T92 |
0-46 |
Sentence |
denotes |
2.2 Cardiovascular manifestations of COVID-19 |
T93 |
48-78 |
Sentence |
denotes |
2.2.1 Acute myocardial injury |
T94 |
79-172 |
Sentence |
denotes |
Acute myocardial injury is the most commonly described CV complication in COVID-19 (Table 1). |
T95 |
173-364 |
Sentence |
denotes |
Different reports have used different definitions for acute myocardial injury, including rise in cardiac enzymes (different biomarkers and cut-offs) and/or electrocardiographic abnormalities. |
T96 |
365-521 |
Sentence |
denotes |
However, an elevation of high-sensitivity cardiac troponin I (cTnI) above 99th percentile upper reference limit is the most commonly used definition.Table 1 |
T97 |
522-682 |
Sentence |
denotes |
The overall incidence of acute cardiac injury has been variable but roughly 8–12% of the positive cases are known to develop significant elevation of cTnI [10]. |
T98 |
683-952 |
Sentence |
denotes |
The aforementioned meta-analysis of the Chinese studies [4] reported 8% incidence of acute cardiac injury whereas another study including only those patients who had had a definite outcome (death or discharge from hospital) reported 17% incidence of cTnI elevation [5]. |
T99 |
953-1114 |
Sentence |
denotes |
Regardless of the actual incidence, acute cardiac injury has been consistently shown to be a strong negative prognostic marker in patients with COVID-19 [5,6,8]. |
T100 |
1115-1233 |
Sentence |
denotes |
The patients admitted to ICU or having severe/fatal illness have several-fold higher likelihood of troponin elevation. |
T101 |
1234-1372 |
Sentence |
denotes |
In contrast, the incidence of elevated troponin has been very low (only 1–2%) in patients having mild illness not requiring ICU admission. |
T102 |
1373-1500 |
Sentence |
denotes |
Any of the mechanisms described above can lead to acute cardiac injury and rise in cardiac troponins in patients with COVID-19. |
T103 |
1501-1725 |
Sentence |
denotes |
The relative role of these different mechanisms has not been described but direct (i.e. non-coronary) myocardial injury due to viral myocarditis or the effect of systemic inflammation appear to be the most common mechanisms. |
T104 |
1726-1862 |
Sentence |
denotes |
These observations are supported by a previous autopsy study in patients who had died due to SARS during the Toronto SARS outbreak [11]. |
T105 |
1863-2024 |
Sentence |
denotes |
In this study, the viral ribonucleic acid was detected in 35% of the autopsied human heart samples, providing evidence for direct myocardial injury by the virus. |
T106 |
2025-2146 |
Sentence |
denotes |
No study has described the incidence of ST-segment elevation myocardial infarction in COVID-19, but it appears to be low. |
T107 |
2147-2296 |
Sentence |
denotes |
Similarly, the incidence of left ventricular systolic dysfunction, acute left ventricular failure and cardiogenic shock have also not been described. |
T108 |
2297-2381 |
Sentence |
denotes |
Only one Chinese study reported incidence of heart failure in COVID-19 patients [5]. |
T109 |
2382-2519 |
Sentence |
denotes |
Heart failure had occurred in 52% of the patients who subsequently died and in 12% of the patients who were discharged from the hospital. |
T110 |
2521-2539 |
Sentence |
denotes |
2.2.2 Arrhythmias |
T111 |
2540-2605 |
Sentence |
denotes |
Both tachy- and brady-arrhythmias are known to occur in COVID-19. |
T112 |
2606-2736 |
Sentence |
denotes |
A study describing clinical profile and outcomes in 138 Chinese patients with COVID-19 reported 16.7% incidence of arrhythmia [8]. |
T113 |
2737-2864 |
Sentence |
denotes |
The incidence was much higher (44.4%) in those requiring ICU admission as compared to those not requiring ICU admission (8.9%). |
T114 |
2865-2906 |
Sentence |
denotes |
The type of arrhythmia was not described. |
T115 |
2908-2947 |
Sentence |
denotes |
2.2.3 Potential long-term consequences |
T116 |
2948-3086 |
Sentence |
denotes |
COVID-19 has emerged only a few months ago and it is too early to predict long-term outcome of the patients who recover from this illness. |
T117 |
3087-3244 |
Sentence |
denotes |
However, some important messages can be gleaned from previous experiences with SARS, caused by SARS-CoV which shares considerable similarity with SARS-CoV-2. |
T118 |
3245-3469 |
Sentence |
denotes |
It was reported that among patients who had recovered from SARS, 68% continued to have abnormalities of lipid metabolism at 12-years follow-up; CV abnormalities were present in 40% and altered glucose metabolism in 60% [12]. |
T119 |
3470-3579 |
Sentence |
denotes |
Similar findings have also been reported in patients recovering from other respiratory tract infections [13]. |
T120 |
3580-3783 |
Sentence |
denotes |
Considering this, careful follow-up of those recovering from the current COVID-19 would be important to understand the long-term impact of this illness and also to protect these patients from future CVD. |